FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Leave a Comment / By Market Social / February 19, 2026

Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug applications process

Post navigation

DoorDash users want more complex deliveries, and that’s hitting profits

Crypto leaders and lawmakers meet at Trump family’s World Liberty Forum: CNBC Crypto World

Your email address will not be published. Required fields are marked *

Comment *

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Markets

Trading

About Us

Name * Only alphabets are allowed.

Password

Again Password

Referral (Optional)

Support Language

Whatsapp Number *

OTP